The DOI matches its Crossref record.
The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility
Open accessAbstract
The urokinase-type plasminogen activator receptor (uPAR) gene was disrupted in mice in order to explore the role of cell surface-associated plasminogen activation in development and hemostasis. Homozygous, uPAR-/- mice were born and survived to adulthood with no overt phenotypic abnormalities. There was no indication of loss of fetal animals based on the Mendelian pattern of transmission of the mutant uPAR gene. uPAR-/- mice carried no detectable uPAR in lung, spleen, and other tissues when measured both immunologically by Western blot analysis and functionally by ligand cross-linking analyses. In addition, activated peritoneal macrophages collected from uPAR-/- mice failed to promote plasminogen activation in vitro. The loss of the receptor also resulted in a redistribution of uPA in some tissues but had no impact on pro-uPA activation in the urogenital tract. Thus, in the absence of other challenging factors such as infection, injury, or other functional deficits, uPAR deficiency does not compromise fertility, development, or hemostasis. These mice provide a means to test the proposed function of uPA/uPAR in wound repair, atherogenesis, and tumor cell invasion in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Senolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098
The plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Identification and functional analysis of endothelial tip cell–enriched genes
del Toro, R., Prahst, C., Mathivet, T., Siegfried, G., Kaminker, J. S., Larrivee, B., Breant, C., Duarte, A., Takakura, N., Fukamizu, A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-270819 · Cited by 474
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
Chapman, H. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80126-3 · Cited by 464
Plasminogen activation and cancer
Behrendt, N., Høyer-Hansen, G., Johnsen, M., Lund, L. R., Ploug, M., Rømer, J., & Danø, K. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0054 · Cited by 452
Self-citationLoss of Fibrinogen Rescues Mice from the Pleiotropic Effects of Plasminogen Deficiency
Bugge, T. H., Kombrinck, K. W., Flick, M. J., Daugherty, C. C., Danton, M. J. S., & Degen, J. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81390-2 · Cited by 424
Self-citationAnnexin II regulates fibrin homeostasis and neoangiogenesis in vivo
Ling, Q., Jacovina, A. T., Deora, A., Febbraio, M., Simantov, R., Silverstein, R. L., Hempstead, B., Mark, W. H., & Hajjar, K. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19684 · Cited by 381
Bacterial plasminogen activators and receptors
Lähteenmäki, K. (2001) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(01)00067-5 · Cited by 359
Basbaum, C. B., & Werb, Z. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80116-5 · Cited by 323
Saharinen, J., Hyytiäinen, M., Taipale, J., & Keski-Oja, J. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00010-6 · Cited by 315
The urokinase plasminogen activator system: a target for anti-cancer therapy
Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312
Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F., & Fazioli, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00502.x · Cited by 299
Bugge, T. H., Flick, M. J., Danton, M. J., Daugherty, C. C., Romer, J., Dano, K., Carmeliet, P., Collen, D., & Degen, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5899 · Cited by 276
Self-citationFunctional overlap between two classes of matrix-degrading proteases in wound healing
Lund, L. R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4645 · Cited by 270
Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo
May, A. E., Kanse, S. M., Lund, L. R., Gisler, R. H., Imhof, B. A., & Preissner, K. T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1029 · Cited by 270
Su, S.-C., Lin, C.-W., Yang, W.-E., Fan, W.-L., & Yang, S.-F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1113260 · Cited by 145
Cheng, Y., Hall, T. R., Xu, X., Yung, I., Souza, D., Zheng, J., Schiele, F., Hoffmann, M., Mbow, M. L., Garnett, J. P., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2021.103758 · Cited by 66
Metrangolo, V., Ploug, M., & Engelholm, L. H. (2021) · Cancers · doi:10.3390/cancers13215376 · Cited by 44
Metadata
- Authors
- Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., R, J., Solberg, H., Ellis, V., Danø, K., & Degen, J. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-07
- Volume
- 270
- Issue
- 28
- Pages
- 16886-16894
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2077310189
- Cited by
- 218
- References
- 0
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.